Prenatal cocaine disrupts serotonin signaling-dependent behaviors: Implications for sex differences, early stress and prenatal SSRI exposure

Current Neuropharmacology

Volumn 9, Issue 3, 2011, Pages 478-511

  Williams, Sarah K ^a   Lauder, Jean M ^a   Johns, Josephine M ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

Aggression; Depression; Development; Early environmental stress; Prenatal antidepressants; Prenatal cocaine; Serotonin; Sex differences

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; COCAINE; DOPAMINE TRANSPORTER; FLUOXETINE; IMIPRAMINE; IPRINDOLE; MIANSERIN; NOMIFENSINE; NORADRENALIN TRANSPORTER; NORFLUOXETINE; PAROXETINE; PROTEIN S100B; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENCE; ADULTHOOD; AGE; AGGRESSION; ALLELE; AMYGDALOID NUCLEUS; ANXIETY DISORDER; ARTICLE; ATTENTION; BASAL GANGLION; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN NERVE CELL; COMMUNICATION SKILL; CORPUS STRIATUM; DEPRESSION; DEVELOPMENTAL STAGE; DISEASE PREDISPOSITION; EARLY LIFE STRESS; EMOTION; ENVIRONMENTAL STRESS; FOREBRAIN; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INFANCY; JUVENILE; LANGUAGE ABILITY; MESENCEPHALON; NERVE CELL GROWTH; NONHUMAN; NUCLEUS ACCUMBENS; PRENATAL EXPOSURE; PROGENY; PUERPERAL DEPRESSION; RAPHE NUCLEUS; RHOMBENCEPHALON; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STRESS;

EID: 79961012017     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015911796557957     Document Type: Article

References (355)

1. Mahalik, M. P.; Gautieri, R. F., and Mann, D. E., Jr. Teratogenic potential of cocaine hydrochloride in CF-1 mice. J. Pharm. Sci., 1980, 69, (6), 703-706.
2. Chasnoff, I. J.; Burns, W. J.; Schnoll, S. H., and Burns, K. A. Co- caine use in pregnancy. N. Engl. J. Med., 1985, 313, (11), 666-669.
3. Chasnoff, I. J.; Bussey, M. E.; Savich, R., and Stack, C. M. Perinatal cerebral infarction and maternal cocaine use. J. Pediatr., 1986, 108, (3), 456-459.
4. Bingol, N.; Fuchs, M.; Diaz, V.; Stone, R. K., and Gromisch, D. S. Teratogenicity of cocaine in humans. J. Pediatr., 1987, 110, (1), 93-96.
5. Blakeslee, S. Crack's Toll Among Babies: A Joyless View, Even of Toys. The New York Times. 1989.
6. Duke, L. Drugs get choke hold in early stages of life: district sees increase in pregnant women who use cocaine, PCP. The Wasington Post. 1988.
7. Kain, Z. N.; Kain, T. S., and Scarpelli, E. M. Cocaine exposure in utero: perinatal development and neonatal manifestations--review. J. Toxicol. Clin. Toxicol.,1992, 30, (4), 607-636.
8. Hannig, V. L. and Phillips, J. A., III. Maternal cocaine abuse and fetal anomalies: evidence for teratogenic effects of cocaine. South Med. J. 1991, 84, (4), 498-499
9. Lester, B. M.; LaGasse, L. L., and Seifer, R. Cocaine exposure and children: the meaning of subtle effects. Science, 1998, 282, (5389), 633-634.
10. Lester, B. M. and Padbury, J. F. Third pathophysiology of prenatal cocaine exposure. Dev. Neurosci., 2009, 31, (1-2), 23-35.
11. Mathias, R. NIDA survey provides first national data on drug use during pregnancy. NIDA Notes, 1995, (6), 7.
12. Office of Applied Studies. Results from the 2006 National Survey on Drug Use and Health: National findings (DHHS Publication No. SMA 07-4293, NSDUH Series H-32). 2007.
13. Behnke, M.; Eyler, F. D.; Conlon, M.; Casanova, O. Q., and Woods, N. S. How fetal cocaine exposure increases neonatal hospital costs. Pediatrics, 1997, 99, (2), 204-208
14. Meyer, K. D. and Zhang, L. Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development. Ther. Adv. Cardiovasc. Dis., 2009, 3, (1), 7-16.
15. Ho, J.; Afshani, E., and Stapleton, F. B. Renal vascular abnormalities associated with prenatal cocaine exposure. Clin. Pediatr. (Phila), 1994, 33, (3), 155-156.
16. ga, C. A.; Brust, J. C.; Bateman, D., and Hauser, W. A. Doseresponse effect of fetal cocaine exposure on newborn neurologic function. Pediatrics, 1999, 103, (1), 79-85.
17. Olsen, G. D. and Murphey, L. J. Effects of morphine and cocaine on breathing control in neonatal animals: a minireview. NIDA Res. Monogr., 1995, 158, 22-39.
18. Glatt, S. J.; Bolanos, C. A.; Trksak, G. H., and Jackson, D. Effects of prenatal cocaine exposure on dopamine system development: a meta-analysis. Neurotoxicol. Teratol., 2000, 22, (5), 617-629.
19. Stanwood, G. D.; Washington, R. A.; Shumsky, J. S., and Levitt, P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience, 2001, 106, (1), 5-14.
20. Bakshi, K.; Gennaro, S.; Chan, C. Y.; Kosciuk, M.; Liu, J.; Stucky, A.; Trenkner, E.; Friedman, E.; Nagele, R. G., and Wang, H. Y. Prenatal cocaine reduces AMPA receptor synaptic expression through hyperphosphorylation of the synaptic anchoring protein GRIP. J. Neurosci., 2009, 29, (19), 6308-6319.
21. McMurray, M. S.; Joyner, P. W.; Middleton, C. W.; Jarrett, T. M.; Elliott, D. L.; Black, M. A.; Hofler, V. E.; Walker, C. H., and Johns, J. M. Intergenerational effects of cocaine on maternal aggressive behavior and brain oxytocin in rat dams. Stress, 2008, 11, (5), 398-410.
22. Cipriani, A.; Brambilla, P.; Furukawa, T.; Geddes, J.; Gregis, M.; Hotopf, M.; Malvini, L., and Barbui, C. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane. Database Syst. Rev., 2005, (4), CD004185-
23. Tatsumi, M.; Groshan, K.; Blakely, R. D., and Richelson, E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol., 1997, 340, (2-3), 249-258.
24. Cabrera, T. M.; Levy, A. D.; Li, Q.; Van de Kar, L. D.; Battagha, G. Cocaine-induced deficits in ACTH and corticosterone responses in female rat progeny. Brain Res. Bull., 1994, 34, 93-9797.
25. Lisboa, S. F.; Oliveira, P. E.; Costa, L. C.; Venancio, E. J., and Moreira, E. G. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology, 2007, 80, (1), 49-56.
26. Oberlander, T. F.; Reebye, P.; Misri, S.; Papsdorf, M.; Kim, J., and Grunau, R. E. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake in-hibitor antidepressant during pregnancy. Arch. Pediatr. Adolesc. Med., 2007, 161, (1), 22-29.
27. Casper, R. C.; Fleisher, B. E.; Lee-Ancajas, J. C.; Gilles, A.; Gaylor, E.; DeBattista, A., and Hoyme, H. E. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J. Pediatr., 2003, 142, (4), 402-408.
28. Bairy, K. L.; Madhyastha, S.; Ashok, K. P.; Bairy, I., and Malini, S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology, 2007, 79, (1), 1-11.
29. Tuccori, M.; Testi, A.; Antonioli, L.; Fornai, M.; Montagnani, S.; Ghisu, N.; Colucci, R.; Corona, T.; Blandizzi, C., and Del Tacca, M. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin. Ther., 2009, 31, (Pt 1), 1426-1453.
30. Gentile, S. and Bellantuono, C. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. J. Clin. Psychiatry, 2009, 70, (3), 414-422.
31. Alwan, S. and Friedman, J. M. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs, 2009, 23, (6), 493-509.
32. Oberlander, T. F.; Gingrich, J. A., and Ansorge, M. S. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther., 2009, 86, (6), 672-677.
33. Zeskind, P. S.; Oberlander, T.; Grunau, R.; Fitzgerald, C., and Garber, K. Continuing effects of prenatal SSRI exposure detected by spectral analysis of infant cry sounds at two months of age. Society for pediatric research. 2005.
34. Barnes, N. M. and Sharp, T. A review of central 5-HT receptors and their function. Neuropharmacology, 1999, 38, (8), 1083-1152.
35. Whitaker-Azmitia, P. M.; Druse, M.; Walker, P., and Lauder, J. M. Serotonin as a developmental signal. Behav. Brain Res., 1996, 73, (1-2), 19-29.
36. Li, Q.; Muma, N. A., and Van De Kar, L. D. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J. Pharmacol. Exp. Ther., 1996, 279, (2), 1035-1042.
37. Li, Q.; Muma, N. A.; Battaglia, G., and Van De Kar, L. D. Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11- proteins. Brain Res., 1997, 775, (1-2), 225-228.
38. Li, Q.; Wichems, C.; Heils, A.; Lesch, K. P., and Murphy, D. L. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J. Neurosci., 2000, 20, (21), 7888-7895.
39. Ritz, M. C.; Cone, E. J., and Kuhar, M. J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci., 1990, 46,(9), 635-645.
40. Meyer, J. S.; Shearman, L. P., and Collins, L. M. Monoamine transporters and the neurobehavioral teratology of cocaine. Pharmacol. Biochem. Behav., 1996, 55, (4), 585-593.
41. Drago, A.; Ronchi, D. D., and Serretti, A. 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Int. J. Neuropsychopharmacol., 2008, 11, (5), 701-721.
42. Chambers, J. J.; Kurrasch-Orbaugh, D. M.; Parker, M. A., and Nichols, D. E. Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists. J. Med. Chem., 2001, 44, (6), 1003-1010.
43. Tsai, S. J.; Wang, Y. C.; Chen, J. Y., and Hong, C. J. Allelic variants of the tryptophan hydroxylase (A218C) and serotonin 1B receptor (A-161T) and personality traits. Neuropsychobiology, 2003, 48, (2), 68-71.
44. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R., and Humphrey, P. P. International Union of Pharmacology classification of receptors for 5- hydroxytryptamine (Serotonin). Pharmacol. Rev., 1994, 46, (2), 157-203.
45. Spear, L. P.; Frambes, N. A., and Kirstein, C. L. Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology (Berl), 1989, 97, (4), 427-431.
46. Whitaker-Azmitia, P. M. and Azmitia, E. C. Astroglial 5-HT1a receptors and S-100 beta in development and plasticity. Perspect. Dev. Neurobiol., 1994, 2, (3), 233-238.
47. Lidov, H. G. and Molliver, M. E. Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res. Bull., 1982, 9, (1-6), 559-604.
48. Wallace, J. A. and Lauder, J. M. Development of the serotonergic system in the rat embryo: an immunocytochemical study. Brain Res. Bull., 1983, 10, (4), 459-479.
49. Lauder, J. M. and Bloom, F. E. Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J. Comp. Neurol., 1974, 155, (4), 469-481.
50. Johns, J. M.; Lubin, D. A.; Lieberman, J. A., and Lauder, J. M. Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspring. Dev. Neurosci., 2002, 24, (6), 522-530.
51. Kessler, F. H.; Woody, G.; Portela, L. V.; Tort, A. B.; De Boni, R.; Peuker, A. C.; Genro, V.; von Diemen, L.; de Souza, D. O., and Pechansky, F. Brain injury markers (S100B and NSE) in chronic cocaine dependents. Rev. Bras. Psiquiatr., 2007, 29, (2), 134-139
52. Akbari, H. M.; Whitaker-Azmitia, P. M., and Azmitia, E. C. Prenatal cocaine decreases the trophic factor S-100 beta and induced microcephaly: reversal by postnatal 5-HT1A receptor agonist. Neurosci. Lett., 1994, 170, (1), 141-144
53. Johns, J. M.; Noonan, L. R.; Zimmerman, L. I.; McMillen, B. A.; Means, L. W.; Walker, C. H.; Lubin, D. A.; Meter, K. E.; Nelson, C. J.; Pedersen, C. A.; Mason, G. A., and Lauder, J. M. Chronic cocaine treatment alters social/aggressive behavior in Sprague- Dawley rat dams and in their prenatally exposed offspring. Ann. N. Y. Acad. Sci., 1998, 846, 399-404.
54. Akbari, H. M.; Kramer, H. K.; Whitaker-Azmitia, P. M.; Spear, L. P., and Azmitia, E. C. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res., 1992, 572, (1/2), 57-63.
55. Clarke, C.; Clarke, K.; Muneyyirci, J.; Azmitia, E., and Whitaker-Azmitia, P. M. Prenatal cocaine delays astroglial maturation: immunodensitometry shows increased markers of immaturity (vimentin and GAP-43) and decreased proliferation and production of the growth factor S-100. Brain Res. Dev. Brain Res., 1996, 91, (2), 268-273
56. Pawluski, J. L.; Galea, L. A.; Brain, U.; Papsdorf, M., and Oberlander, T. F. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics, 2009, 124, (4), e662-e670.
57. Tramontina, A. C.; Tramontina, F.; Bobermin, L. D.; Zanotto, C.; Souza, D. F.; Leite, M. C.; Nardin, P.; Gottfried, C., and Goncalves, C. A. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32, (6), 1580-1583.
58. Jang, B. S.; Kim, H.; Lim, S. W.; Jang, K. W., and Kim, D. K. Serum S100B Levels and major depressive disorder: Its Characteristics and role in antidepressant response. Psychiatry Investig., 2008, 5, (3), 193-198.
59. Schroeter, M. L.; Abdul-Khaliq, H.; Diefenbacher, A., and Blasig, I. E. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport, 2002, 13, (13), 1675-1678.
60. Nassogne, M. C.; Gressens, P.; Evrard, P., and Courtoy, P. J. In contrast to cocaine, prenatal exposure to methadone does not produce detectable alterations in the developing mouse brain. Brain Res. Dev. Brain Res., 1998, 110, (1), 61-67.
61. Donato, R.; Sorci, G.; Riuzzi, F.; Arcuri, C.; Bianchi, R.; Brozzi, F.; Tubaro, C., and Giambanco, I. S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta, 2009, 1793, (6), 1008-1022.
62. Rothermundt, M.; Ponath, G., and Arolt, V. S100B in schizophrenic psychosis. Int. Rev. Neurobiol., 2004, 59, 445-470.
63. Whitaker-Azmitia, P. M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull., 2001, 56, (5), 479-485.
64. Yang, K.; Xie, G. R.; Hu, Y. Q.; Mao, F. Q., and Su, L. Y. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression. J. Neural Transm., 2008, 115, (12), 1687-1694.
65. Machado-Vieira, R.; Lara, D. R.; Portela, L. V.; Goncalves, C. A.; Soares, J. C.; Kapczinski, F., and Souza, D. O. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur. Neuropsychopharmacol., 2002, 12 (3), 269-272.
66. Cabrera-Vera, T. M.; Garcia, F.; Pinto, W., and Battaglia, G. Neurochemical changes in brain serotonin neurons in immature and adult offspring prenatally exposed to cocaine. Brain Res., 2000, 870, (1-2), 1-9.
67. Song, J.; Guan, X. W.; Ren, J. Q., and He, W. Developmental toxicity of cocaine exposure in mid-pregnancy mice. Acta Pharmacol. Sin., 2002, 23, (11), 1029-1034.
68. Rudnick, G. and Wall, S. C. p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry, 1992, 31, (29), 6710-6718.
69. ch, H. The serotonin syndrome. Am. J. Psychiatry, 1991, 148, (6), 705-713.
70. Bruning, G.; Liangos, O., and Baumgarten, H. G. Prenatal development of the serotonin transporter in mouse brain. Cell Tissue Res., 1997, 289, (2), 211-221.
71. Shuey, D. L.; Sadler, T. W., and Lauder, J. M. Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology, 1992, 46, (4), 367-378.
72. Shuey, D. L.; Sadler, T. W.; Tamir, H., and Lauder, J. M. Serotonin and morphogenesis. Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse. Anat. Embryol. (Berl). 1993, 187, (1), 75-85.
73. Yavarone, M. S.; Shuey, D. L.; Sadler, T. W., and Lauder, J. M. Serotonin uptake in the ectoplacental cone and placenta of the mouse. Placenta, 1993. 14, (2), 149-161.
74. Yan, Q. Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine expo- sure. Brain Res., 2002, 929, 59-69.
75. Laine, K.; Heikkinen, T.; Ekblad, U., and Kero, P. Effects of expo-sure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch. Gen. Psychiatry, 2003, 60, (7), 720-726.
76. Hilli, J.; Heikkinen, T.; Rontu, R.; Lehtimaki, T.; Kishida, I.; Aklillu, E.; Bertilsson, L.; Vahlberg, T., and Laine, K. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. Eur. Neuropsycho- pharmacol., 2009, 19, (5), 363-370.
77. Henderson, M. G. and McMillen, B. A. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat off- spring after in utero exposure to cocaine or related drugs. Teratology, 1993, 48, (5), 421-430.
78. Cabrera-Vera, T. M.; Garcia, F.; Pinto, W., and Battaglia, G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J. Pharmacol. Exp. Ther., 1997, 280, (1), 138-145.
79. Tuinier, S.; Verhoeven, W. M., and van Praag, H. M. Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reap-praisal of the clinical data. Int. Clin. Psychopharmacol., 1995, 10, (3), 147-156.
80. Asberg, M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann. N. Y. Acad. Sci., 1997, 836, 158-181.
81. Needlman, R.; Zuckerman, B.; Anderson, G. M.; Mirochnick, M., and Cohen, D. J. Cerebrospinal fluid monoamine precursors and metabolites in human neonates following in utero cocaine exposure: a preliminary study. Pediatrics,1993, 92, (1), 55-60.
82. Macedo, T.; Ribeiro, C. A.; Cotrim, D.; Tavares, P.; Morgadinho, M. T.; Caramona, M.; Vicente, M. T.; Rodrigues, L.; Cardoso, M. G., and Keating, M. L. Catecholamine and MHPG plasma levels, platelet MAO activity, and 3H-imipramine binding in heroin and cocaine addicts. Mol. Neurobiol.,1995, 11, (1-3), 21-29.
83. Nicotra, A.; Pierucci, F.; Parvez, H., and Senatori, O. Monoamine oxidase expression during development and aging. Neurotoxicology, 2004, 25, (1-2), 155-165.
84. Cipriani, A.; Geddes, J. R.; Furukawa, T. A., and Barbui, C. Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can. J. Psychiatry, 2007, 52, (9), 553-562.
85. Battaglia, G. and Cabrera, T. M. Potentiation of 5-HT1A receptor-mediated neuroendocrine responses in male but not female rat progeny after prenatal cocaine: evidence for gender differences. J. Pharmacol. Exp. Ther., 1994, 271, (3), 1453-1461.
86. McReynolds, A. M. and Meyer, J. S. Effects of prenatal cocaine exposure on serotonin and norepinephrine transporter density in the rat brain. Ann. N. Y. Acad. Sci., 1998, 846, 412-414.
87. Montero, D.; de Ceballos, M. L., and Del Rio, J. Down-regulation of 3H-imipramine binding sites in cerebral cortex after prenatal exposure to antidepressants. Life Sci., 1990, 46, 1619-1626.
88. Cabrera-Vera, T. M. and Battaglia, G. Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies. J. Pharmacol. Exp. Ther., 1998, 286, (3), 1474-1481.
89. Jovanovic, H.; Lundberg, J.; Karlsson, P.; Cerin, A.; Saijo, T.; Varrone, A.; Halldin, C., and Nordstrom, A. L. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage, 2008, 39, (3), 1408-1419.
90. Vigod, S. N. and Stewart, D. E. Emergent research in the cause of mental illness in women across the lifespan. Curr. Opin. Psychia- try, 2009, 22, (4), 396-400.
91. Forcelli, P. A. and Heinrichs, S. C. Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking be- havior in offspring. Addict. Biol., 2008, 13, (1), 52-62.
92. Barr, C. S.; Newman, T. K.; Schwandt, M.; Shannon, C.; Dvoskin, R. L.; Lindell, S. G.; Taubman, J.; Thompson, B.; Champoux, M.; Lesch, K. P.; Goldman, D.; Suomi, S. J., and Higley, J. D. Sexual dichotomy of an interaction between early adversity and the sero- tonin transporter gene promoter variant in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A., 2004, 101, (33), 12358-12363.
93. Sjoberg, R. L.; Nilsson, K. W.; Nordquist, N.; Ohrvik, J.; Leppert, J.; Lindstrom, L., and Oreland, L. Development of depression: sex and the interaction between environment and a promoter poly- morphism of the serotonin transporter gene. Int. J. Neuropsycho- pharmacol., 2006, 9, (4), 443-449.
94. Miquel, M. C.; Doucet, E.; Riad, M.; Adrien, J.; Verge, D., and Hamon, M. Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain. Brain Res. Mol. Brain Res., 1992, 14, (4), 357-362.
95. Centenaro, L. A.; Vieira, K.; Zimmermann, N.; Miczek, K. A.; Lucion, A. B., and De Almeida, R. M. Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex. Psychopharmacology (Berl), 2008. 201, (2), 237-248.
96. Fuller, R. W. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav. Brain Res., 1996, 73, (1-2), 215-219.
97. Cabrera, T. M.; Yracheta, J. M.; Li, Q.; Levy, A. D.; Van De Kar, L. D., and Battaglia, G. Prenatal cocaine produces deficits in serotonin mediated neuroendocrine responses in adult rat progeny: evidence for long-term functional alterations in brain serotonin path-ways. Synapse, 1993, 15, (2), 158-168.
98. Vicentic, A.; Cabrera-Vera, T. M.; Pinto, W., and Battaglia, G. 5- HT(1A) and 5-HT(2A) serotonin receptor turnover in adult rat off- spring prenatally exposed to cocaine. Brain Res., 2000, 877, (2), 141-148.
99. Li, Q.; Muma, N. A.; Battaglia, G., and Van De Kar, L. D. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5- HT1A receptors. J. Pharmacol. Exp. Ther., 1997, 282, (3), 1581-1590.
100. Chen, Z.; Tetzlaff, J.; Sripathirathan, K.; Carrasco, G. A.; Shankaran, M.; Van De Kar, L. D.; Muma, N. A., and Battaglia, G. Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine. Psychopharmacology (Berl), 2005, 180, (2), 316-326.
101. da Silva, V. A.; Altenburg, S. P.; Malheiros, L. R.; Thomaz, T. G., and Lindsey, C. J. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz. J. Med. Biol. Res., 1999, 32, (1), 93-98.
102. Azmitia, E. C.; Gannon, P. J.; Kheck, N. M., and Whitaker- Azmitia, P. M. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology, 1996, 14, (1), 35-46.
103. Kia, H. K.; Brisorgueil, M. J.; Hamon, M.; Calas, A., and Verge, D. Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. J. Neurosci. Res., 1996. 46, (6), 697-708.
104. Jorgensen, H. S. Studies on the neuroendocrine role of serotonin. Dan. Med. Bull., 2007, 54, (4), 266-288.
105. Calogero, A. E.; Bagdy, G.; Szemeredi, K.; Tartaglia, M. E.; Gold, P. W., and Chrousos, G. P. Mechanisms of serotonin receptor ago-nist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology, 1990, 126, (4), 1888-1894.
106. Maswood, S.; Stewart, G., and Uphouse, L. Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypotha-lamic serotonin. Pharmacol. Biochem. Behav., 1995, 51, (4), 807-813.
107. Bolanos, C. A.; Trksak, G. H.; Cohen, O. S., and Jackson, D. Differential serotonergic inhibition of in vitro striatal [3H] acetylcholine release in prenatally cocaine-exposed male and fe- male rats. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2002, 26, (7-8), 1339-1348.
108. Zhang, L.; Ma, W.; Barker, J. L., and Rubinow, D. R. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience, 1999, 94, (1), 251-259.
109. Gogos, A. and van den, B. M. Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behav. Neurosci., 2003, 117, (6), 1407-1415.
110. Raum, W. J.; McGivern, R. F.; Peterson, M. A.; Shryne, J. H., and Gorski, R. A. Prenatal inhibition of hypothalamic sex steroid up- take by cocaine: effects on neurobehavioral sexual differentiation in male rats. Brain Res. Dev. Brain Res., 1990, 53, (2), 230-236.
111. Albonetti, E.; Gonzalez, M. I.; Siddiqui, A.; Wilson, C. A., and Farabollini, F. Involvement of the 5-HT1A subtype receptor in the neonatal organization of agonistic behaviour in the rat. Pharmacol. Biochem. Behav., 1996, 54, (1), 189-193.
112. Battaglia, G.; Cabrera-Vera, T. M., and Van De Kar, L. D. Prenatal cocaine exposure potentiates 5-HT(2a) receptor function in male and female rat offspring. Synapse, 2000, 35, (3), 163-172.
113. Maier, W.; Mossner, R.; Quednow, B. B.; Wagner, M., and Hurlemann, R. From genes to psychoses and back: the role of the 5HT2alpha-receptor and prepulse inhibition in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci., 2008, 258 Suppl 5, 40-43.
114. Dwivedi, Y.; Mondal, A. C.; Payappagoudar, G. V., and Rizavi, H. S. Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior. Neuropharmacology, 2005, 48, (2), 204-214.
115. Nomura, M. and Nomura, Y. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann. N. Y. Acad. Sci. 2006, 1086, 134-143
116. Henderson, M. G.; McConnaughey, M. M., and McMillen, B. A. Long-term consequences of prenatal exposure to cocaine or related drugs: effects on rat brain monoaminergic receptors. Brain Res. Bull., 1991, 26, (6), 941-945.
117. Cabrera, T. M. and Battaglia, G. Delayed decreases in brain 5- hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine. J. Pharmacol. Exp. Ther., 1994, 269, (2), 637-645.
118. Romero, G.; Toscano, E., and Del Rio, J. Effect of prenatal exposure to antidepressants on 5-HT-stimulated phosphoinositide hydrolysis and 5-HT2 receptors in rat brain. Gen. Pharmacol., 1994, 25, (5), 851-856.
119. de Ceballos, M. L.; Benedi, A.; Urdin, C., and Del Rio, J. Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex. Lack of correlation between 5-HT2 receptors and serotonin-mediated behaviour. Neuropharmacology, 1985, 24, (10), 947-952.
120. Williams, S. K.; Jarrett, T. M.; Lycan, T.; McMurray, M. S.; Riday, T.; Obispo-Peak, I.; Lauder, J. M., and Johns, J. M. Effects of prenatal cocaine exposure on 5-HT2A receptors in adult rats. Abstr.- Soc. Neurosci., 2006, 393, 22.
121. Chen, Z.; Waimey, K.; Van De Kar, L. D.; Carrasco, G. A.; Lan- dry, M., and Battaglia, G. Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring. Neuropharmacology, 2004, 46, (7), 942-953.
122. Poncelet, M.; Perio, A.; Simiand, J.; Gout, G.; Soubrie, P., and Le Fur, G. Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents. J. Neural Transm. Gen. Sect., 1995, 102, (2), 83-90.
123. Engleman, E. A.; Rodd, Z. A.; Bell, R. L., and Murphy, J. M. The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol. Disord. Drug Targets, 2008, 7, (5), 454-467.
124. Cervantes, M. C. and Delville, Y. Serotonin 5-HT1A and 5-HT3 receptors in an impulsive-aggressive phenotype. Behav. Neurosci., 2009, 123, (3), 589-598.
125. Bolanos, C. A.; Trksak, G. H.; Glatt, S. J., and Jackson, D. Prenatal cocaine exposure increases serotonergic inhibition of electrically evoked acetylcholine release from rat striatal slices at adulthood. Synapse, 2000, 36, (1), 1-11.
126. Lesch, K. P. Serotonergic gene expression and depression: implications for developing novel antidepressants. J. Affect. Disord., 2001, 62, (1-2), 57-76.
127. Alenina, N.; Bashammakh, S., and Bader, M. Specification and differentiation of serotonergic neurons. Stem Cell Rev., 2006, 2, (1), 5-10.
128. Goridis, C. and Rohrer, H. Specification of catecholaminergic and serotonergic neurons. Nat. Rev. Neurosci., 2002, 3, (7), 531-541.
129. Koebbe, M. J.; Golden, J. A.; Bennett, G.; Finnell, R. H., and Mackler, S. A. Effects of prenatal cocaine exposure on embryonic expression of sonic hedgehog. Teratology, 1999, 59, (1), 12-19.
130. Fox, M. A.; Andrews, A. M.; Wendland, J. R.; Lesch, K. P.; Holmes, A., and Murphy, D. L. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl), 2007, 195, (2), 147-166.
131. Akimova, E.; Lanzenberger, R., and Kasper, S. The serotonin-1A receptor in anxiety disorders. Biol. Psychiatry, 2009, 66, (7), 627-635.
132. Ase, A. R.; Reader, T. A.; Hen, R.; Riad, M., and Descarries, L. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem., 2001, 78, (3), 619-630
133. Chae, S. M. and Covington, C. Y. Biobehavioral outcomes in adolescents and young adults prenatally exposed to cocaine: evidence from animal models. Biol. Res. Nurs., 2009, 10, (4), 318-330.
134. Frank, D. A.; Augustyn, M.; Knight, W. G.; Pell, T., and Zuckerman, B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA, 2001, 285, (12), 1613-1625.
135. Delaney-Black, V.; Covington, C.; Templin, T.; Kershaw, T.; Nordstrom-Klee, B.; Ager, J.; Clark, N.; Surendran, A.; Martier, S., and Sokol, R. J. Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J. Commun. Disord., 2000, 33, (6), 463-480.
136. Spear, L. P.; Silveri, M. M.; Casale, M.; Katovic, N. M.; Campbell, J. O., and Douglas, L. A. Cocaine and development: a retrospective perspective. Neurotoxicol. Teratol., 2002. 24, (3), 321-327.
137. Whitaker-Azmitia, P. M. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int. J. Dev. Neurosci., 2005, 23, (1), 75-83.
138. Lord, C.; Cook, E. H.; Leventhal, B. L., and Amaral, D. G. Autism spectrum disorders. Neuron, 2000, 28, (2), 355-363.
139. Mayes, L. C. A behavioral teratogenic model of the impact of prenatal cocaine exposure on arousal regulatory systems. Neurotoxicol. Teratol., 2002, 24, (3), 385-395.
140. Mayes, L. C.; Grillon, C.; Granger, R., and Schottenfeld, R. Regulation of arousal and attention in preschool children exposed to co- caine prenatally. Ann. N. Y. Acad. Sci., 1998, 846, 126-143.
141. Coles, C. D.; Bard, K. A.; Platzman, K. A., and Lynch, M. E. Attentional response at eight weeks in prenatally drug-exposed and preterm infants. Neurotoxicol. Teratol., 1999, 21, (5), 527-537.
142. Bendersky, M. and Lewis, M. Arousal modulation in cocaine- exposed infants. Dev. Psychol., 1998, 34, (3), 555-564.
143. Wilens, T. E. and Spencer, T. J. Understanding attention- deficit/hyperactivity disorder from childhood to adulthood. Postgrad. Med., 2010, 122, (5), 97-109.
144. Hughes, R. N. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci. Biobehav. Rev., 2004, 28, (5), 497-505.
145. Karmel, B. Z. and Gardner, J. M. Prenatal cocaine exposure effects on arousal-modulated attention during the neonatal period. Dev. Psychobiol., 1996, 29, (5), 463-480.
146. Zeskind, P. S.; Schuetze, P.; Coles, C. D., and Platzman, K. Prenatal cocaine exposure and infant cry reactivity: A longitudinal analysis in the newborn period. Society for research in Child Development 1993.
147. Accornero, V. H.; Amado, A. J.; Morrow, C. E.; Xue, L.; Anthony, J. C., and Bandstra, E. S. Impact of prenatal cocaine exposure on attention and response inhibition as assessed by continuous performance tests. J. Dev. Behav. Pediatr., 2007, 28, (3), 195-205.
148. Kable, J. A.; Coles, C. D.; Lynch, M. E., and Platzman, K. Physiological responses to social and cognitive challenges in 8-year olds with a history of prenatal cocaine exposure. Dev. Psychobiol., 2008, 50, (3), 251-265.
149. Linares, T. J.; Singer, L. T.; Kirchner, H. L.; Short, E. J.; Min, M. O.; Hussey, P., and Minnes, S. Mental health outcomes of cocaine- exposed children at 6 years of age. J. Pediatr. Psychol., 2006, 31, (1), 85-97.
150. Bada, H. S.; Langer, J.; Twomey, J.; Bursi, C.; LaGasse, L.; Bauer, C. R.; Shankaran, S.; Lester, B. M.; Higgins, R., and Maza, P. L. Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure. J. Dev. Behav. Pediatr., 2008, 29, (3), 173-182.
151. Li, Z.; Coles, C. D.; Lynch, M. E.; Hamann, S.; Peltier, S.; LaConte, S., and Hu, X. Prenatal cocaine exposure alters emotional arousal regulation and its effects on working memory. Neurotoxicol. Teratol., 2009, 31, (6), 342-348.
152. Li, Z.; Santhanam, P.; Coles, C. D.; Lynch, M. E.; Hamann, S.; Peltier, S., and Hu, X. Increased default mode activity in adolescents prenatally exposed to cocaine. Hum. Brain Mapp., 2010. [Epub ahead of prin].
153. Smith, R. F.; Mattran, K. M.; Kurkjian, M. F., and Kurtz, S. L. Alterations in offspring behavior induced by chronic prenatal co- caine dosing. Neurotoxicol. Teratol., 1989, 11, (1), 35-38.
154. Johns, J. M.; Means, M. J.; Anderson, D. R.; Bass, E. W.; Means, L. W., and McMillen, B. A. Prenatal exposure to cocaine: II. Effects on open field activity and cognitive behavior in Sprague- Dawley rats. Neurotoxicol. Teratol., 1992, 14, 343-349.
155. Zeskind, P. S. and Stephens, L. E. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics, 2004, 113, (2), 368-375.
156. Figueroa, R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J. Dev. Behav. Pediatr., 2010, 31, (8), 641-648.
157. Vorhees, C. V.; Acuff-Smith, K. D.; Schilling, M. A.; Fisher, J. E.; Moran, M. S., and Buelke-Sam, J. A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam. Appl. Toxicol., 1994, 23, (2), 194-205.
158. Gendle, M. H.; Strawderman, M. S.; Mactutus, C. F.; Booze, R. M.; Levitsky, D. A., and Strupp, B. J. Impaired sustained attention and altered reactivity to errors in an animal model of prenatal co- caine exposure. Brain Res. Dev. Brain Res., 2003, 147, (1-2), 85-96.
159. Gendle, M. H.; White, T. L.; Strawderman, M.; Mactutus, C. F.; Booze, R. M.; Levitsky, D. A., and Strupp, B. J. Enduring effects of prenatal cocaine exposure on selective attention and reactivity to errors: evidence from an animal model. Behav. Neurosci., 2004, 118, (2), 290-297.
160. Wilkins, A. S.; Jones, K., and Kosofsky, B. E. Transplacental co- caine exposure. 2: Effects of cocaine dose and gestational timing. Neurotoxicol. Teratol., 1998, 20, (3), 227-238.
161. Brunzell, D. H.; Ayres, J. J., and Meyer, J. S. Effects of prenatal cocaine exposure on latent inhibition in 1-year-old female rats. Pharmacol. Biochem. Behav., 2002, 72, (4), 795-802.
162. Retz, W. and Rosler, M. The relation of ADHD and violent aggression: What can we learn from epidemiological and genetic studies? Int. J. Law Psychiatry, 2009, 32, (4), 235-243.
163. Hofvander, B.; Ossowski, D.; Lundstrom, S., and Anckarsater, H. Continuity of aggressive antisocial behavior from childhood to adulthood: The question of phenotype definition. Int. J. Law Psychiatry, 2009, 32, (4), 224-234.
164. Dalley, J. W.; Mar, A. C.; Economidou, D., and Robbins, T. W. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol. Biochem. Behav., 2008, 90, (2), 250-260.
165. Winstanley, C. A.; Theobald, D. E.; Dalley, J. W.; Cardinal, R. N., and Robbins, T. W. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb. Cortex, 2006, 16, (1), 106-114.
166. Dommett, E. J.; Overton, P. G., and Greenfield, S. A. Drug therapies for attentional disorders alter the signal-to-noise ratio in the superior colliculus. Neuroscience, 2009, 164, (3), 1369-1376.
167. Pompeiano, M.; Palacios, J. M., and Mengod, G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J. Neurosci., 1992, 12, (2), 440-453.
168. Winstanley, C. A.; Theobald, D. E.; Dalley, J. W., and Robbins, T. W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology, 2005, 30, (4), 669-682.
169. Spencer, T. J.; Biederman, J.; Madras, B. K.; Faraone, S. V.; Dougherty, D. D.; Bonab, A. A., and Fischman, A. J. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol. Psychiatry, 2005, 57, (11), 1293-1300.
170. Bayer, L. E.; Brown, A.; Mactutus, C. F.; Booze, R. M., and Strupp, B. J. Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297. J. Neurosci., 2000, 20, (23), 8902-8908.
171. Daviss, W. B. A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J. Child Adolesc. Psychopharmacol., 2008, 18, (6), 565-571.
172. Alex, K. D. and Pehek, E. A. Pharmacologic mechanisms of sero- tonergic regulation of dopamine neurotransmission. Pharmacol. Ther., 2007, 113, (2), 296-320.
173. Oberlander, T. F.; Grunau, R.; Mayes, L.; Riggs, W.; Rurak, D.; Papsdorf, M.; Misri, S., and Weinberg, J. Hypothalamic-pituitary- adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant expo-sure. Early Hum. Dev., 2008, 84, (10), 689-697.
174. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry, 1960, 23, 56-62.
175. Pellow, S.; Chopin, P.; File, S. E., and Briley, M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 1985. 14, (3), 149-167.
176. Ramos, A. Animal models of anxiety: do I need multiple tests? Trends Pharmacol. Sci., 2008, 29, (10), 493-498.
177. Pollak, D. D.; Rey, C. E., and Monje, F. J. Rodent models in depression research: classical strategies and new directions. Ann. Med., 2010, 42, (4), 252-264.
178. Blumberg, M. S. and Sokoloff, G. Do infant rats cry? Psychol.Rev., 2001, 108, (1), 83-95.
179. Blumberg, M. S. and Alberts, J. R. Ultrasonic vocalizations by rat pups in the cold: an acoustic by-product of laryngeal braking? Behav. Neurosci., 1990, 104, (5), 808-817.
180. Brunelli, S. A.; Aviles, J. A.; Gannon, K. S.; Branscomb, A., and Shacham, S. PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety. Pharmacol. Biochem. Behav., 2009, 94, (1), 8-15.
181. Fish, E. W.; Faccidomo, S.; Gupta, S., and Miczek, K. A. Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. J. Pharmacol. Exp. Ther., 2004, 308, (2), 474-480.
182. Hammerness, P.; Geller, D.; Petty, C.; Lamb, A.; Bristol, E., and Biederman, J. Does ADHD moderate the manifestation of anxiety disorders in children? Eur. Child Adolesc. Psychiatry, 2010, 19, (2), 107-112.
183. Cox, E. T.; Jones, G.; Williams, S. K.; McMurray, M. S.; Jamieson-Drake A.; Zeskind, P. S.; Hodge C.; Grewen, K. M., and Johns, J. M. Prenatal cocaine exposure alters human and rodent infant vocalizations: implications for maternal care and neural integrity. Proc. Intl. Behav. Neurosci. Soc., 2010 [Epub ahead of print].
184. Cox, E. T.; Sheikh M.; Williams, S. K.; McMurray, M. S., and Johns, J. M. Prenatal cocaine exposure alters rodent pup ultrasonic vocalizations that might impact the mother-infant relationship: A preliminary study. Abstr.- Soc.Neurosci., 2009 [Epub ahead of print].
185. Overstreet, D. H.; Moy, S. S.; Lubin, D. A.; Gause, L. R.; Lieberman, J. A., and Johns, J. M. Enduring effects of prenatal cocaine administration on emotional behavior in rats. Physiol. Behav., 2000, 70, (1-2), 149-156.
186. Johns, J. M. and Noonan, L. R. Prenatal cocaine exposure affects social behavior in Sprague-Dawley rats. Neurotoxicol. Teratol., 1995, 17, (5), 569-576.
187. Johns, J. M.; Means, M. J.; Means, L. W., and McMillen, B. A. Prenatal exposure to cocaine: I. Effects on gestation, development and activity in Sprague-Dawley rats. Neurotoxicol. Teratol., 1992, 14, 337-342.
188. Church, M. W.; Holmes, P. A.; Overbeck, G. W.; Tilak, J. P., and Zajac, C. S. Interactive effects of prenatal alcohol and cocaine exposures on postnatal mortality, development and behavior in the Long-Evans rat. Neurotoxicol. Teratol., 1991, 13, (4), 377-386.
189. Misri, S.; Reebye, P.; Kendrick, K.; Carter, D.; Ryan, D.; Grunau, R. E., and Oberlander, T. F. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am. J. Psychiatry, 2006, 163, (6), 1026-1032.
190. Coleman, F. H.; Christensen, H. D.; Gonzalez, C. L., and Rayburn, W. F. Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil). Am. J. Obstet. Gynecol., 1999, 181, (5 Pt 1), 1166-1171.
191. File, S. E. and Tucker, J. C. Prenatal treatment with clomipramine has an anxiolytic profile in the adolescent rat. Physiol. Behav., 1983, 31, (1), 57-61.
192. Sobrian, S. K.; Marr, L., and Ressman, K. Prenatal cocaine and/or nicotine exposure produces depression and anxiety in aging rats. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2003, 27, (3), 501-518.
193. Salas-Ramirez, K. Y.; Frankfurt, M.; Alexander, A.; Luine, V. N., and Friedman, E. Prenatal cocaine exposure increases anxiety, impairs cognitive function and increases dendritic spine density in adult rats: influence of sex. Neuroscience, 2010,169, (3), 1287-1295.
194. Gau, S. S.; Ni, H. C.; Shang, C. Y.; Soong, W. T.; Wu, Y. Y.; Lin, L. Y., and Chiu, Y. N. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder. Aust. N. Z. J. Psychiatry, 2010, 44, (2), 135-143.
195. Savitz, J.; Lucki, I., and Drevets, W. C. 5-HT(1A) receptor function in major depressive disorder. Prog. Neurobiol., 2009, 88, (1), 17-31.
196. Dawson, L. A. and Watson, J. M. Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders. CNS Neurosci. Ther., 2009, 15, (2), 107-117.
197. Krishnan, V. and Nestler, E. J. The molecular neurobiology of depression. Nature, 2008, 455, (7215), 894-902.
198. Holsboer, F. and Ising, M. Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur. J. Pharmacol., 2008, 583, (2-3), 350-357.
199. Su, S. W.; Cherng, C. F.; Lin, Y. C., and Yu, L. Prenatal exposure of bupropion may enhance agitation, anxiety responses, and sensitivity to cocaine effects in adult mice. Chin J. Physiol., 2007, 50, (1), 1-8.
200. Herman, J. P. and Cullinan, W. E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci., 1997, 20, (2), 78-84.
201. Pittenger, C. and Duman, R. S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology, 2008, 33, (1), 88-109.
202. Muller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J. M.; Timpl, P.; Kormann, M. S.; Droste, S. K.; Kuhn, R.; Reul, J. M.; Holsboer, F., and Wurst, W. Limbic corticotropin- releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci., 2003, 6, (10), 1100-1107.
203. Spear, L. P. Assessment of the effects of developmental toxicants: pharmacological and stress vulnerability of offspring. NIDA Res.Monogr., 1996, 164, 125-145.
204. Magnano, C. L.; Gardner, J. M., and Karmel, B. Z. Differences in salivary cortisol levels in cocaine-exposed and noncocaine-exposed NICU infants. Dev. Psychobiol., 1992, 25, (2), 93-103.
205. Jacobson, S. W.; Bihun, J. T., and Chiodo, L. M. Effects of prenatal alcohol and cocaine exposure on infant cortisol levels. Dev. Psychopathol., 1999, 11, (2), 195-208.
206. Lester, B. M.; LaGasse, L. L.; Shankaran, S.; Bada, H. S.; Bauer, C. R.; Lin, R.; Das, A., and Higgins, R. Prenatal cocaine exposure related to cortisol stress reactivity in 11-Year-old children. J. Pediatr., 2010, 157, (2), 288-295.
207. Goodwin, G. A.; Bliven, T.; Kuhn, C.; Francis, R., and Spear, L. P. Immediate early gene expression to examine neuronal activity following acute and chronic stressors in rat pups: Examination of neurophysiological alterations underlying behavioral consequences of prenatal cocaine exposure. Physiol. Behav., 1997, 61, (6), 895-902.
208. Battaglia G. C. T. Potentiation of 5-HT1A Receptor-Mediated neuro- endocrine responses in male but not female rat progeny after prental cocaine: evidence for gender differences. J. Pharmacol. Exp. Ther., 1994, 271, 1453-1461.
209. Choi, S. J.; Mazzio, E. A.; Reams, R. R., and Soliman, K. F. Gestational cocaine exposure alters postnatal pituitary-adrenal axis activity and stress endurance in rats. Ann. N. Y. Acad. Sci., 1998, 844, 336-345.
210. Planeta, C. S.; Berliner, J.; Russ, A., and Kosofsky, B. E. The effect of prenatal cocaine exposure on the stress response of adult mice. Neurotox. Res., 2001, 3, (1), 53-64.
211. Huber, J.; Darling, S.; Park, K., and Soliman, K. F. Altered responsiveness to stress and NMDA following prenatal exposure to co- caine. Physiol. Behav., 2001, 72, (1-2), 181-188.
212. Lowry, C. A. and Moore, F. L. Regulation of behavioral responses by corticotropin-releasing factor. Gen. Comp Endocrinol., 2006, 146, (1), 19-27.
213. Bluet Pajot, M. T.; Mounier, F.; di Sciullo, A.; Schmidt, B., and Kordon, C. Differential sites of action of 8OHDPAT, a 5HT1A agonist, on ACTH and PRL secretion in the rat. Neuroendocrinol- ogy, 1995,61, (2), 159-166.
214. Lowry, C. A.; Hale, M. W.; Plant, A.; Windle, R. J.; Shanks, N.; Wood, S. A.; Ingram, C. D.; Renner, K. J.; Lightman, S. L., and Summers, C. H. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats. Stress, 2009, 12, (3), 225-239.
215. Eiden, R. D.; McAuliffe, S.; Kachadourian, L.; Coles, C.; Colder, C., and Schuetze, P. Effects of prenatal cocaine exposure on infant reactivity and regulation. Neurotoxicol. Teratol., 2009, 31, (1), 60-68.
216. Chaplin, T. M.; Fahy, T.; Sinha, R., and Mayes, L. C. Emotional arousal in cocaine exposed toddlers: prediction of behavior problems. Neurotoxicol. Teratol., 2009, 31, (5), 275-282.
217. Molitor, A.; Mayes, L. C., and Ward, A. Emotion regulation behavior during a separation procedure in 18-month-old children of mothers using cocaine and other drugs. Dev. Psychopathol., 2003, 15, (1), 39-54.
218. Dennis, T.; Bendersky, M.; Ramsay, D., and Lewis, M. Reactivity and regulation in children prenatally exposed to cocaine. Dev. Psychol., 2006, 42, (4), 688-697.
219. Spear, L. P.; Kirstein, C. L.; Bell, J.; Yoottanasumpun, V.; Greenbaum, R.; O'Shea, J.; Hoffmann, H., and Spear, N. E. Effects of prenatal cocaine exposure on behavior during the early postnatal period. Neurotoxicol. Teratol., 1989, 11, (1), 57-63.
220. Heyser, C. J.; McKinzie, D. L.; Athalie, F.; Spear, N. E., and Spear, L. P. Effects of prenatal exposure to cocaine on heart rate and non- associative learning and retention in infant rats. Teratology, 1994, 49, (6), 470-478.
221. Nulman, I.; Rovet, J.; Stewart, D. E.; Wolpin, J.; Pace-Asciak, P.; Shuhaiber, S., and Koren, G. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am. J. Psychiatry, 2002, 159, (11), 1889-1895.
222. Wood, R. D.; Molina, V. A.; Wagner, J. M., and Spear, L. P. Play behavior and stress responsivity in periadolescent offspring exposed prenatally to cocaine. Pharmacol. Biochem. Behav., 1995, 52, (2), 367-374.
223. Morrow, B. A.; Elsworth, J. D., and Roth, R. H. Male rats exposed to cocaine in utero demonstrate elevated expression of Fos in the prefrontal cortex in response to environment. Neuropsychopharmacology, 2002, 26, (3), 275-285.
224. Bilitzke, P. J. and Church, M. W. Prenatal cocaine and alcohol exposures affect rat behavior in a stress test (the Porsolt swim test). Neurotoxicol. Teratol.,1992, 14, (5), 359-364.
225. Molina, V. A.; Wagner, J. M., and Spear, L. P. The behavioral response to stress is altered in adult rats exposed prenatally to co-caine. Physiol. Behav., 1994, 55, (5), 941-945.
226. Campbell, J. O.; Bliven, T. D.; Silveri, M. M.; Snyder, K. J., and Spear, L. P. Effects of prenatal cocaine on behavioral adaptation to chronic stress in adult rats. Neurotoxicol. Teratol., 2000, 22, (6), 845-850.
227. Johns, J. M.; Knapp, D. J., and Noonan, L. R. Prenatal exposure to cocaine treatment alters ultrasonic vocalizations to air puffs in adult female rat Offspring. Abstr. Soc. Neurosci., 1994, 20, 250.
228. Hsiao, S. Y.; Cherng, C. F.; Yang, Y. K.; Yeh, T. L., and Yu, L. Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice. Chin J. Physiol., 2005, 48, (4), 223-229.
229. Gingras, J. L.; Feibel, J. B.; Dalley, L. B.; Muelenaer, A., and Knight, C. G. Maternal polydrug use including cocaine and postnatal infant sleep architecture: preliminary observations and implications for respiratory control and behavior. Early Hum. Dev., 1995, 43, (3),197-204.
230. Regalado, M. G.; Schechtman, V. L.; Del Angel, A. P., and Bean, X. D. Cardiac and respiratory patterns during sleep in cocaine- exposed neonates. Early Hum. Dev., 1996, 44, (3), 187-200.
231. Scafidi, F. A.; Field, T. M.; Wheeden, A.; Schanberg, S.; Kuhn, C.; Symanski, R.; Zimmerman, E., and Bandstra, E. S. Cocaine-exposed preterm neonates show behavioral and hormonal differences. Pediatrics, 1996, 97, (6 Pt 1), 851-855.
232. Delville, Y.; Newman, M. L.; Wommack, J. C.; Taravosh-Lahn, K., and Cervantes, M. C. Devel. Aggression, 2006, (14), 327-350.
233. Blonigen D.M. and Krueger R.F. Human quantitative genetics of aggression. 2006, (2), 20-37.
234. Blanchard, D. C.; Fukunaga-Stinson, C.; Takahashi, L. K.; Flannelly, K. J., and Blanchard, R. J. Dominance and aggression in social groups of male and female rats. Behav. Processes, 1984, 9, 31-48.
235. Bendersky, M.; Bennett, D., and Lewis, M. Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J. Pediatr. Psychol., 2006, 31, (1), 71-84.
236. Bennett, D.; Bendersky, M., and Lewis, M. Preadolescent health risk behavior as a function of prenatal cocaine exposure and gender. J. Dev. Behav. Pediatr., 2007, 28, (6), 467-472.
237. Reef, J.; Diamantopoulou, S.; van, M., I; Verhulst, F., and van der, E. J. Predicting adult emotional and behavioral problems from externalizing problem trajectories in a 24-year longitudinal study. Eur. Child Adolesc. Psychiatry, 2010, 19, (7), 577-585.
238. Wood, R. D. and Spear, L. P. Prenatal cocaine alters social competition of infant, adolescent, and adult rats. Behav. Neurosci., 1998, 112, (2), 419-431.
239. Estelles, J.; Rodriguez-Arias, M.; Maldonado, C.; Manzanedo, C.; Aguilar, M. A., and Minarro, J. Prenatal cocaine alters later responses to morphine in adult male mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30, (6), 1073-1082.
240. Johns, J. M.; Means, M. J.; Bass, E. W.; Means, L. W.; Zimmerman, L. I., and McMillen, B. A. Prenatal exposure to cocaine: effects on aggression in Sprague-Dawley rats. Dev. Psychobiol., 1994, 27, (4), 227-239.
241. Singh, Y.; Jaiswal, A. K.; Singh, M., and Bhattacharya, S. K. Effect of prenatal diazepam, phenobarbital, haloperidol and fluoxetine exposure on foot shock induced aggression in rats. Indian J. Exp. Biol., 1998, 36, (10), 1023-1024.
242. Miczek, K. A.; Mos, J., and Olivier, B. Brain 5-HT and inhibition of aggressive behavior in animals: 5-HIAA and receptor subtypes. Psychopharmacol. Bull., 1989, 25, (3), 399-403.
243. Miczek, K. A.; De Almeida, R. M.; Kravitz, E. A.; Rissman, E. F.; de Boer, S. F., and Raine, A. Neurobiology of escalated aggression and violence. J. Neurosci., 2007, 27, (44), 11803-11806.
244. Carrillo, M.; Ricci, L. A.; Coppersmith, G. A., and Melloni, R. H., Jr. The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacology (Berl), 2009, 205, (3), 349-368.
245. Ricci, L. A.; Knyshevski, I., and Melloni, R. H., Jr. Serotonin type 3 receptors stimulate offensive aggression in Syrian hamsters. Behav. Brain Res., 2005, 156, (1), 19-29.
246. Witte, A. V.; Floel, A.; Stein, P.; Savli, M.; Mien, L. K.; Wadsak, W.; Spindelegger, C.; Moser, U.; Fink, M.; Hahn, A.; Mitterhauser, M.; Kletter, K.; Kasper, S., and Lanzenberger, R. Aggression is re- lated to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum. Brain Mapp., 2009, 30, (8), 2558-2570.
247. de Boer, S. F. and Koolhaas, J. M. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur. J. Pharmacol., 2005, 526, (1-3), 125-139.
248. Ricci, L. A.; Rasakham, K.; Grimes, J. M., and Melloni, R. H., Jr. Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol. Biochem. Behav., 2006, 85, (1), 1-11.
249. Hutson, P. H.; Sarna, G. S.; O'Connell, M. T., and Curzon, G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci. Lett., 1989,100, (1-3), 276-280.
250. Muller, C. P.; Carey, R. J.; Huston, J. P., and Souza Silva, M. A. Serotonin and psychostimulant addiction: focus on 5-HT1A- receptors. Prog. Neurobiol., 2007, 81, (3), 133-178.
251. Carey, R. J.; DePalma, G.; Shanahan, A.; Damianopoulos, E. N.; Muller, C. P., and Huston, J. P. Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems. Pharmacol. Biochem. Behav., 2008, 89, (1), 54-63.
252. Young, K. A.; Liu, Y., and Wang, Z. The neurobiology of social attachment: A comparative approach to behavioral, neuroanatomical, and neurochemical studies. Comp. Biochem. Physiol C. Toxicol. Pharmacol., 2008, 148, (4), 401-410.
253. Willey, A. R.; Varlinskaya, E. I., and Spear, L. P. Social interac- tions and 50 kHz ultrasonic vocalizations in adolescent and adult rats. Behav. Brain Res., 2009, 202, (1), 122-129.
254. Panksepp, J. The ontogeny of play in rats. Dev. Psychobiol., 1981, 14, (4), 327-332.
255. Pellis, S. M. and Pellis, V. C. Play fighting of rats in comparative perspective: a schema for neurobehavioral analyses. Neurosci. Biobehav. Rev., 1998, 23, (1), 87-101.
256. Varlinskaya, E. I. and Spear, L. P. Acute ethanol withdrawal (hangover) and social behavior in adolescent and adult male and female Sprague-Dawley rats. Alcohol Clin. Exp. Res., 2004, 28, (1), 40-50.
257. Lewis, M. W.; Phillips, G.; Bowser, M.; DeLuca, S.; Johnson, H. L., and Rosen, T. S. Cocaine-exposed infant behavior during Still- Face: risk factor analyses. Am. J. Orthopsychiatry, 2009, 79, (1), 60-70.
258. Davis, E.; Fennoy, I.; Laraque, D.; Kanem, N.; Brown, G., and Mitchell, J. Autism and developmental abnormalities in children with perinatal cocaine exposure. J. Natl. Med. Assoc., 1992, 84, (4), 315-319.
259. Jones, N. A.; Field, T.; Davalos, M., and Hart, S. Greater right frontal EEG asymmetry and nonemphathic behavior are observed in children prenatally exposed to cocaine. Int. J. Neurosci., 2004, 114, (4), 459-480.
260. Johns, J. M.; Elliott, D. L.; Hofler, V. E.; Joyner, P. W.; McMurray, M. S.; Jarrett, T. M.; Haslup, A. M.; Middleton, C. L.; Elliott, J. C., and Walker, C. H. Cocaine treatment and prenatal environment interact to disrupt intergenerational maternal behavior in rats. Behav. Neurosci., 2005, 119, (6), 1605-1618.
261. Spear, L.; Snyder, K.; Krantova, Y., and Campbell, J. Effects of prenatal cocaine exposure and maternal separation on heart rate, orienting response habituation, and retention. Dev. Psychobiol., 2003, 42, (2), 160-170.
262. Wood, R. D.; Bannoura, M. D., and Johanson, I. B. Prenatal cocaine exposure: effects on play behavior in the juvenile rat. Neurotoxicol. Teratol., 1994, 16, (2), 139-144.
263. Johns, J. M.; McMurray, M. S.; Hofler, V. E.; Jarrett, T. M.; Middleton, C. L.; Elliott, D. L.; Mirza, R.; Haslup, A.; Elliott, J. C., and Walker, C. H. Cocaine disrupts pup-induced maternal behavior in juvenile and adult rats. Neurotoxicol. Teratol., 2007, 29, 634-641.
264. Reiersen, A. M. and Todd, R. D. Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert Rev. Neurother., 2008, 8, (4), 657-669.
265. Brodkin, E. S. BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behav. Brain Res., 2007, 176, (1), 53-65.
266. Higley, J. D.; King, S. T., Jr.; Hasert, M. F.; Champoux, M.; Suomi, S. J., and Linnoila, M. Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females. Neuropsychopharmacology, 1996, 14, (1), 67-76
267. Maestripieri, D.; Lindell, S. G.; Ayala, A.; Gold, P. W., and Higley, J. D. Neurobiological characteristics of rhesus macaque abusive mothers and their relation to social and maternal behavior. Neurosci. Biobehav. Rev., 2005, 29, (1), 51-57.
268. Claussen, A. H.; Mundy, P. C.; Mallik, S. A., and Willoughby, J. C. Joint attention and disorganized attachment status in infants at risk. Dev. Psychopathol., 2002, 14, (2), 279-291.
269. Sharp, H. M. and Hillenbrand, K. Speech and language development and disorders in children. Pediatr. Clin. North Am., 2008, 55, (5), 1159-73, viii.
270. Kuhl, P. K. Brain mechanisms in early language acquisition. Neuron, 2010, 67, (5), 713-727.
271. Cone-Wesson, B. Prenatal alcohol and cocaine exposure: influences on cognition, speech, language, and hearing. J. Commun. Disord., 2005, 38, (4), 279-302.
272. Morrow, C. E.; Vogel, A. L.; Anthony, J. C.; Ofir, A. Y.; Dausa, A. T., and Bandstra, E. S. Expressive and receptive language functioning in preschool children with prenatal cocaine exposure. J. Pedi- atr. Psychol., 2004, 29, (7), 543-554.
273. Beeghly, M.; Martin, B.; Rose-Jacobs, R.; Cabral, H.; Heeren, T.; Augustyn, M.; Bellinger, D., and Frank, D. A. Prenatal cocaine exposure and children's language functioning at 6 and 9.5 years: moderating effects of child age, birthweight, and gender. J. Pediatr. Psychol., 2006, 31, (1), 98-115.
274. Lewis, B. A.; Kirchner, H. L.; Short, E. J.; Minnes, S.; Weishampel, P.; Satayathum, S., and Singer, L. T. Prenatal cocaine and tobacco effects on children's language trajectories. Pediatrics, 2007, 120, (1), e78-e85.
275. Pulsifer, M. B.; Butz, A. M.; O'Reilly, F. M., and Belcher, H. M. Prenatal drug exposure: effects on cognitive functioning at 5 years of age. Clin. Pediatr. (Phila), 2008, 47, (1), 58-65.
276. Hurt, H.; Betancourt, L. M.; Malmud, E. K.; Shera, D. M.; Giannetta, J. M.; Brodsky, N. L., and Farah, M. J. Children with and without gestational cocaine exposure: a neurocognitive systems analysis. Neurotoxicol. Teratol., 2009, 31, (6), 334-341.
277. Singer, L. T.; Minnes, S.; Short, E.; Arendt, R.; Farkas, K.; Lewis, B.; Klein, N.; Russ, S.; Min, M. O., and Kirchner, H. L. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA, 2004, 291, (20), 2448-2456.
278. Burke, A. E.; Crenshaw, D. A.; Green, J.; Schlosser, M. A., and Strocchia-Rivera, L. Influence of verbal ability on the expression of aggression in physically abused children. J. Am. Acad. Child Ado- lesc. Psychiatry, 1989, 28, (2), 215-218.
279. Brudzynski, S. M. Principles of rat communication: quantitative parameters of ultrasonic calls in rats. Behav. Genet., 2005, 35, (1), 85-92.
280. Brunelli, S. A.; Shair, H. N., and Hofer, M. A. Hypothermic vocalizations of rat pups (Rattus norvegicus) elicit and direct maternal search behavior. J. Comp. Psychol., 1994. 108, (3), 298-303.
281. Barron, S.; Hansen-Trench, L. S., and Kaiser, D. H. Neonatal cocaine exposure and activity rhythms in rats. Behav. Brain Res., 1996, 74, (1-2), 167-174.
282. Barron, S.; Segar, T. M.; Yahr, J. S.; Baseheart, B. J., and Willford, J. A. The effects of neonatal ethanol and/or cocaine exposure on isolation-induced ultrasonic vocalizations. Pharmacol. Biochem. Behav., 2000, 67, (1), 1-9.
283. Barron, S. and Gilbertson, R. Neonatal ethanol exposure but not neonatal cocaine selectively reduces specific isolation-induced vocalization waveforms in rats. Behav. Genet., 2005, 35, (1), 93-102.
284. Hahn, M. E.; Benno, R. H.; Schanz, N., and Phadia, E. The effects of prenatal cocaine exposure and genotype on the ultrasonic calls of infant mice. Pharmacol. Biochem. Behav., 2000, 67, (4), 729-738.
285. Kehoe, P. and Boylan, C. B. Cocaine-induced effects on isolation stress in neonatal rats. Behav. Neurosci., 1992, 106, (2), 374-379.
286. McMurray, M. S.; Zeskind, P. S.; Moy, S. S.; Jarrett, T. M., and Johns, J. M. Preliminary effects of in Utero cocaine exposure on infant rat ultrasonic vocalizations. Proc. Intl. Behav. Neurosci. Soc., 2006, 46-47.
287. Williams, S. K.; Cox, E. T.; Heaton C.F.; Desai N.N.; Fay, E. E.; McMurray, M. S., and Johns, J. M. Gestational cocaine affects ma- ternal motivation and pup preference: Possible dependence on pup vocalizations. Abstr.- Soc. Neurosci., 2010.
288. Olivier, B.; Molewijk, H. E.; van der Heyden, J. A.; van Oorschot, R.; Ronken, E.; Mos, J., and Miczek, K. A. Ultrasonic vocaliza- tions in rat pups: effects of serotonergic ligands. Neurosci. Biobehav. Rev., 1998, 23, (2), 215-227.
289. Hodgson, R. A.; Guthrie, D. H., and Varty, G. B. Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs. Pharmacol. Biochem. Behav., 2008, 88, (3), 341-348.
290. Bardin, L.; Gregoire, S.; Aliaga, M.; Malfetes, N.; Vitton, O.; Ladure, P.; Newman-Tancredi, A., and Depoortere, R. Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats. Neurosci. Res., 2010, 66, (2), 135-140.
291. Burgdorf, J.; Panksepp, J.; Brudzynski, S. M.; Beinfeld, M. C.; Cromwell, H. C.; Kroes, R. A., and Moskal, J. R. The effects of se- lective breeding for differential rates of 50-kHz ultrasonic vocaliza- tions on emotional behavior in rats. Dev. Psychobiol., 2009, 51, (1), 34-46.
292. Wohr, M.; Houx, B.; Schwarting, R. K., and Spruijt, B. Effects of experience and context on 50-kHz vocalizations in rats. Physiol. Behav., 2008, 93, (4-5), 766-776.
293. Mayes, L. C.; Feldman, R.; Granger, R. H.; Haynes, O. M.; Bornstein, M. H., and Schottenfeld, R. The effects of polydrug use with and without cocaine on mother-infant interaction at 3 and 6 months. Infant Behav. Dev., 1997, 20, (4), 489-502.
294. Light, K. C.; Smith, T. E.; Johns, J. M.; Brownley, K. A.; Hofheimer, J. A., and Amico, J. A. Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity. Health Psychol., 2000, 19, (6), 560-567.
295. Neuspiel, D. R.; Hamel, S. C.; Hochberg, E.; Greene, J., and Campbell, D. Maternal cocaine use and infant behavior. Neurotoxicol. Teratol., 1991, 13, (2), 229-233.
296. Minnes, S.; Singer, L. T.; Arendt, R., and Satayathum, S. Effects of prenatal cocaine/polydrug use on maternal-infant feeding interac- tions during the first year of life. J. Dev. Behav. Pediatr., 2005, 26, (3), 194-200.
297. Burns, K.; Chethik, L.; Burns, W. J., and Clark, R. Dyadic distur- bances in cocaine-abusing mothers and their infants. J. Clin. Psychol., 1991, 47, (2), 316-319.
298. Murphy, J. M.; Jellinek, M.; Quinn, D.; Smith, G.; Poitrast, F. G., and Goshko, M. Substance abuse and serious child mistreatment: prevalence, risk, and outcome in a court sample. Child Abuse Negl., 1991, 15, (3), 197-211.
299. Nair, P.; Black, M. M.; Schuler, M.; Keane, V.; Rigney, B. A., and Magder, L. Risk factors for disruption in primary caregiving among infants of substance abusing women. Child Abuse Negl., 1997, 21, (11), 1039-1051.
300. Leventhal, J. M.; Forsyth, B. W.; Qi, K.; Johnson, L.; Schroeder, D., and Votto, N. Maltreatment of children born to women who used cocaine during pregnancy: a population-based study. Pediatrics, 1997, 100, (2), E7.
301. Wasserman, D. R. and Leventhal, J. M. Maltreatment of children born to cocaine-dependent mothers. Am. J. Dis. Child, 1993, 147, 1324-1328.
302. Johns, J. M.; Noonan, L. R.; Zimmerman, L. I.; Li, L., and Pedersen, C. A. Effects of short-and long-term withdrawal from gestational cocaine treatment on maternal behavior and aggression in Sprague-Dawley rats. Dev. Neurosci., 1997, 19, (4), 368-374.
303. Johns, J. M.; Noonan, L. R.; Zimmerman, L. I.; Li, L., and Pedersen, C. A. Effects of chronic and acute cocaine treatment on the on-set of maternal behavior and aggression in Sprague-Dawley rats. Behav. Neurosci., 1994, 108, (1), 107-112.
304. Kinsley, C. H.; Turco, D.; Bauer, A.; Beverly, M.; Wellman, J., and Graham, A. L. Cocaine alters the onset and maintenance of mater- nal behavior in lactating rats. Pharmacol. Biochem. Behav., 1994, 47, (4), 857-864.
305. Elliott, J. C.; Lubin, D. A.; Walker, C. H., and Johns, J. M. Acute cocaine alters oxytocin levels in the medial preoptic area and amygdala in lactating rat dams: implications for cocaineinduced changes in maternal behavior and maternal aggression. Neuropeptides, 2001, 35, (2), 127-134.
306. Johns, J. M.; Nelson, C. J.; Meter, K. E.; Lubin, D. A.; Couch, C. D.; Ayers, A., and Walker, C. H. Dose-dependent effects of multi- ple acute cocaine injections on maternal behavior and aggression in Sprague-Dawley rats. Dev. Neurosci., 1998, 20, (6), 525-532.
307. Vernotica, E. M. and Morrell, J. I. Plasma cocaine levels and loco- motor activity after systemic injection in virgin and in lactating maternal female rats. Physiol. Behav., 1998, 64, (3), 399-407.
308. Zeskind, P. S.; Platzman, K.; Coles, C. D., and Schuetze, P. Cry analysis detects subclinical effects of prenatal alcohol exposure. In- fant Behav. Dev., 1996, 19, (4), 497-500.
309. Brunk, M. A. and Henggeler, S. W. Child influences on adult con- trols: An experimental investigation. Dev. Psychol., 1984, 20, (6), 1074-1081.
310. Belsky, J. Etiology of child maltreatment: a developmental- ecological analysis. Psychol. Bull., 1993, 114, (3), 413-434.
311. Stern, J. M. and Mackinnon, D. A. Sensory regulation of maternal behavior in rats: effects of pup age. Dev. Psychobiol., 1978, 11, (6), 579-586.
312. Stern, J. M. and Azzara, A. V. Thermal control of mother-young contact revisited: hyperthermic rats nurse normally. Physiol. Behav., 2002, 77, (1), 11-18.
313. Stern, J. M. Offspring-induced nurturance: animal-human parallels. Dev. Psychobiol., 1997, 31, (1), 19-37.
314. Logsdon, M. C.; Wisner, K., and Hanusa, B. H. Does maternal role functioning improve with antidepressant treatment in women with postpartum depression? J. Womens Health (Larchmt.), 2009, 18, (1), 85-90.
315. Johns, J. M.; Joyner, P. W.; McMurray, M. S.; Elliott, D. L.; Hofler, V. E.; Middleton, C. L.; Knupp, K.; Greenhill, K. W.; Lomas, L. M., and Walker, C. H. The effects of dopaminergic/serotonergic reuptake inhibition on maternal behavior, maternal aggression, and oxytocin in the rat. Pharmacol. Biochem. Behav., 2005, 81, (4), 769-785.
316. Philip, N. S.; Carpenter, L. L.; Tyrka, A. R., and Price, L. H. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J. Psychiatr. Pract., 2008, 14, (1), 34-44.
317. Li, M.; Budin, R.; Fleming, A. S., and Kapur, S. Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats. Psychopharmacology (Berl)., 2005, 181, (3), 600-610.
318. Lavi-Avnon, Y.; Yadid, G.; Overstreet, D. H., and Weller, A. Abnormal patterns of maternal behavior in a genetic animal model of depression. Physiol. Behav., 2005, 84, (4), 607-615.
319. Braw, Y.; Malkesman, O.; Merenlender, A.; Dagan, M.; Bercovich, A.; Lavi-Avnon, Y., and Weller, A. Divergent maternal behavioral patterns in two genetic animal models of depression. Physiol. Behav., 2009,96, (2), 209-217.
320. Smith, J. W.; Seckl, J. R.; Evans, A. T.; Costall, B., and Smythe, J. W. Gestational stress induces post-partum depression-like behaviour and alters maternal care in rats. Psychoneuroendocrinology, 2004, 29, (2), 227-244.
321. Chen, Y.; Holzman, C.; Chung, H.; Senagore, P.; Talge, N. M., and Siler-Khodr, T. Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics. Psychoneuroendocrinology, 2010, 35, (6), 820-832
322. Poobalan, A. S.; Aucott, L. S.; Ross, L.; Smith, W. C.; Helms, P. J., and Williams, J. H. Effects of treating postnatal depression on mother-infant interaction and child development: systematic review. Br. J. Psychiatry, 2007, 191, 378-386.
323. Shipman, K. and Taussig, H. Mental health treatment of child abuse and neglect: the promise of evidence-based practice. Pediatr. Clin. North Am., 2009, 56, (2), 417-428.
324. Briere, J. and Jordan, C. E. Childhood maltreatment, intervening variables, and adult psychological difficulties in women: an over- view. Trauma Violence Abuse, 2009, 10, (4), 375-388.
325. Fish, E. W.; Shahrokh, D.; Bagot, R.; Caldji, C.; Bredy, T.; Szyf, M., and Meaney, M. J. Epigenetic programming of stress responses through variations in maternal care. Ann. N. Y. Acad. Sci., 2004, 1036, 167-180.
326. Veenema, A. H. Early life stress, the development of aggression and neuroendocrine and neurobiological correlates: what can we learn from animal models? Front Neuroendocrinol., 2009, 30, (4), 497-518.
327. Stanger, C.; Higgins, S. T.; Bickel, W. K.; Elk, R.; Grabowski, J.; Schmitz, J.; Amass, L.; Kirby, K. C., and Seracini, A. M. Behavioral and emotional problems among children of cocaine- and opiate-dependent parents. J. Am. Acad. Child Adolesc. Psychiatry, 1999, 38, (4), 421-428.
328. Goodwin, G. A.; Heyser, C. J.; Moody, C. A.; Rajachandran, L.; Molina, V. A.; Arnold, H. M.; McKinzie, D. L.; Spear, N. E., and Spear, L. P. A fostering study of the effects of prenatal cocaine exposure: II. Offspring behavioral measures. Neurotoxicol. Teratol., 1992, 14, (6), 423-432.
329. Pedersen, C. A. and Boccia, M. L. Oxytocin links mothering received, mothering bestowed and adult stress responses. Stress, 2002, 5, (4), 259-267.
330. Liu, D.; Diorio, J.; Tannenbaum, B.; Caldji, C.; Francis, D.; Freedman, A.; Sharma, S.; Pearson, D.; Plotsky, P. M., and Meaney, M. J. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science, 1997, 277, (5332), 1659-1662.
331. Meaney, M. J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci., 2001, 24, 1161-1192.
332. Francis, D. D.; Champagne, F. A.; Liu, D., and Meaney, M. J. Maternal care, gene expression, and the development of individual differences in stress reactivity. Ann. N. Y. Acad. Sci., 1999, 896, 66-84.
333. Carter, D. A. and Lightman, S. L. Oxytocin stress responses are dependent upon emotionality. Psychoneuroendocrinology, 1987, 12, (3), 219-223.
334. Windle, R. J.; Shanks, N.; Lightman, S. L., and Ingram, C. D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology, 1997,138, (7), 2829-2834.
335. Neumann, I. D.; Torner, L., and Wigger, A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience, 2000, 95, (2), 567-575.
336. Spear, L. P. and Scalzo, F. M. Ontogenetic alterations in the effects of food and/or maternal deprivation on 5-HT, 5-HIAA and 5- HIAA/5-HT ratios. Brain Res., 1985, 350, (1-2), 143-157.
337. Zhang, T. Y. and Meaney, M. J. Epigenetics and the environmental regulation of the genome and its function. Annu. Rev. Psychol., 2010, 61, 439-3.
338. Weaver, I. C.; Cervoni, N.; Champagne, F. A.; D'Alessio, A. C.; Sharma, S.; Seckl, J. R.; Dymov, S.; Szyf, M., and Meaney, M. J. Epigenetic programming by maternal behavior. Nat. Neurosci., 2004, 7, (8), 847-854.
339. Weaver, I. C.; D'Alessio, A. C.; Brown, S. E.; Hellstrom, I. C.; Dymov, S.; Sharma, S.; Szyf, M., and Meaney, M. J. The transcrip- tion factor nerve growth factor-inducible protein a mediates epige- netic programming: altering epigenetic marks by immediate-early genes. J. Neurosci., 2007, 27, (7), 1756-1768.
340. Weaver, I. C. Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off. Epigenetics, 2007, 2, (1), 22-28.
341. Ichise, M.; Vines, D. C.; Gura, T.; Anderson, G. M.; Suomi, S. J.; Higley, J. D., and Innis, R. B. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J. Neurosci., 2006, 26, (17), 4638-4643.
342. Shannon, C.; Schwandt, M. L.; Champoux, M.; Shoaf, S. E.; Suomi, S. J.; Linnoila, M., and Higley, J. D. Maternal absence and stability of individual differences in CSF 5-HIAA concentrations in rhesus monkey infants. Am. J. Psychiatry, 2005, 162, (9), 1658-1664.
343. Miller, J. M.; Kinnally, E. L.; Ogden, R. T.; Oquendo, M. A.; Mann, J. J., and Parsey, R. V. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder. Synapse, 2009, 63, (7), 565-573.
344. Matsuzaki, H.; Izumi, T.; Matsumoto, M.; Togashi, H.; Yamaguchi, T.; Yoshida, T.; Watanabe, M., and Yoshioka, M. Early postnatal stress affects 5-HT1A receptor function in the medial prefrontal cortex in adult rats. Eur. J. Pharmacol., 2009, 615, (1-3), 76-82.
345. Oreland, S.; Pickering, C.; Gokturk, C.; Oreland, L.; Arborelius, L., and Nylander, I. Two repeated maternal separation procedures differentially affect brain 5-hydroxytryptamine transporter and receptors in young and adult male and female rats. Brain Res., 2009, 1305 Suppl, S37-S49.
346. Roy, A. Self-rated childhood emotional neglect and CSF monoamine indices in abstinent cocaine-abusing adults: possible implications for suicidal behavior. Psychiatry Res., 2002, 112, (1), 69-75.
347. Zanettini, C.; Carola, V.; Lo, I. L.; Moles, A.; Gross, C., and D'Amato, F. R. Postnatal handling reverses social anxiety in serotonin receptor 1A knockout mice. Genes Brain Behav., 2010, 9, (1), 26-32.
348. Field, T.; Diego, M.; Hernandez-Reif, M.; Vera, Y.; Gil, K.; Schanberg, S.; Kuhn, C., and Gonzalez-Garcia, A. Prenatal mater- nal biochemistry predicts neonatal biochemistry. Int. J. Neurosci., 2004, 114, (8), 933-945.
349. Araya, R.; Hu, X.; Heron, J.; Enoch, M. A.; Evans, J.; Lewis, G.; Nutt, D., and Goldman, D. Effects of stressful life events, maternal depression and 5-HTTLPR genotype on emotional symptoms in pre-adolescent children. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2009, 150B, (5), 670-682.
350. Schwandt, M. L.; Lindell, S. G.; Sjoberg, R. L.; Chisholm, K. L.; Higley, J. D.; Suomi, S. J.; Heilig, M., and Barr, C. S. Gene- environment interactions and response to social intrusion in male and female rhesus macaques. Biol. Psychiatry, 2010, 67, (4), 323-330.
351. Oberlander, T. F.; Bonaguro, R. J.; Misri, S.; Papsdorf, M.; Ross, C. J., and Simpson, E. M. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol. Psychiatry, 2008, 13, (1), 65-73.
352. Lee, Y. S.; Choi, S. W.; Han, D. H.; Kim, D. J., and Joe, K. H. Clinical manifestation of alcohol withdrawal symptoms related to genetic polymorphisms of two serotonin receptors and serotonin transporter. Eur. Addict. Res., 2009, 15, (1), 39-46.
353. Popova, N. K. From gene to aggressive behavior: the role of brain serotonin. Neurosci. Behav. Physiol., 2008, 38, (5), 471-475.
354. Biederman, J. Attention-deficit/hyperactivity disorder: a selective overview. Biol. Psychiatry, 2005, 57, (11), 1215-1220.
355. Friedman, E. and Wang, H. Y. Prenatal cocaine exposure alters signal transduction in the brain D1 dopamine receptor system. Ann. N. Y. Acad. Sci., 1998, 846, 238-247.